IDL Biotech to strengthen global sales
IDL Biotech today announced that they are strengthening their global Sales and Marketing team. Martyn Eales has been named Senior Vice President of Global Sales and Marie Torstensson has been named Marketing Manager. Together they will lead the effort to increase international sales.
Martyn Eales has long experience from Life Science sales and business development. His experience will be advantageous in relation to the company’s planned expansion phase, both in current markets in Europe and Asia, as well as in new markets globally.
Marie Torstensson has worked as Product Manager for IDL Biotech since 2012. Prior to joining IDL Marie has held management positions at Boerhinger Ingelheim Svanova. Her experience of product management within diagnostics industry will be a great support for IDL´s renewed marketing effort.
Together with the previously appointed scientific advisors, Professor Per-Anders Abrahamsson and Professor Claes Henning, IDL will be in a strong position to increase the number of clinical studies and develop a clear pathway to increased sales.
“I am excited by the addition of these positions. Together, this exceptionally strong team, will provide IDL with a robust platform for increased international sales” says Charlotte Berg, CEO at IDL Biotech.
IDL Biotech AB (publ) är ett publikt svenskt bioteknikbolag, specialiserat på in vitro diagnostik inom onkologi och bakteriologi. Bolaget utvecklar, producerar och marknadsför unika och kostnadseffektiva produkter för medicinskt angelägna indikationer. IDL Biotech AB (publ) har ett etablerat internationellt distributörsnätverk. Bolagets aktier (IDL B) är noterade på Aktietorget.